OOIR: Observatory of International Research

Papers

(The H4-Index of Metabolism-Clinical and Experimental is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset	901
The Conicity Index in Identification of Cardiorenal Metabolic Syndrome Patients at Increased Risk for Complications	794
EMI Not Just BMI: Unveiling Hidden Diabetes Risk Among Apparently Healthy U.S. Young Adults	271
Lifestyle and Affective Emotions in Patients with Type 2 Diabetes Mellitus, With or Without COVID-19 History	237
MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation	223
Healthcare Professionals’ Perceptions of Obesity & Agonists of the Glucagon, GLP-1 & GIP Receptors	169
The role of active vitamin D in preventing sarcopenia—Authors' reply	158
PFKFB3 nuclear translocation improves diabetic retinopathy by attenuating endothelial cell senescence through inhibition of USP7-p53 axis	155
Angiopoietin-like protein 8 mediates inflammation and fibrosis of tubular cells in diabetic kidney disease progression by interacting with Akt2	155
Editorial Board	153
Editorial Board	144
Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and High Blood Pressure: Results from CATALYST	138
Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice	132
Natural selection signatures of 65 syndromic and 8 monogenic obesity genes in 7 ethnic groups do not support the thrifty genotype hypothesis	132
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity	129
Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy	128
Molecular code of ferroptosis: emerging multi-dimensional modifications and therapeutic targets in hepatic disorders	115
Consensus statement on vitamin D role in metabolic health	114
Corrigendum to “Emerging roles of arginine metabolism in skeletal health and disease” [Metabolism 2025 Nov 19:175:156451. / PMID: 41270967]	109
Brown adipose tissue-derived metabolites and their role in regulating metabolism	106
Sarcopenia does not have adverse effects on insulin sensitivity in women with obesity	102
Cost–Benefit Management of Insulin Resistance: Combination of Phentermine and a Flexible Weight Loss Strategy in the Era of GLP-1 Agonists. Visible Benefits Shown After Six Months of Treatment	101
Insulin Resistance: An APOE4 Equivalent for Human Cerebral Cortical Amyloid Deposition	101
The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review	92
Sepsis-induced lipid droplet accumulation enhances antibacterial innate immunity through mechanisms dependent on DGAT-1 and interferon-beta	87

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis	87
Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states	82
PCSK9 in metabolism and diseases	82
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity	81
PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy	78
Protein oxidation in non-exercising healthy adults under varying dietary conditions: Physiological determinants, effects on fuel partitioning, and implications for body weight regulation	76
Exercise training increases skeletal muscle sphingomyelinases and affects mitochondrial quality control in men with type 2 diabetes	75
Uncovering mechanisms of thiazolidinediones on osteogenesis and adipogenesis using spatial fluxomics	74
Risk of Obesity, Diabetes, Insulin resistance, and Dyslipidemia among Irritable Bowel Syndrome patients	72
Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications	72
The relationship between Vitamin D level and Sarcopenia: Insights from a Korean Population Study	72
Editorial Board	72
Relationship between Obesity Indices Measured with Body Composition Analyzer and Carotid Artery Plaques in Korean Middle-Aged Men	69
Higher Resource Utilization And Mortality Among Patients With Heart Failure Admited With Diabetic Ketoacidosis And Chronic Kidney Disease	68
Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease	68
Role of mitochondria in pathogenesis and therapy of renal fibrosis	67
Corrigendum to “FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis” [Metabolism 122 (September 2021) 154840]	66
Fatty acid metabolism: The crossroads in intestinal homeostasis and tumor	65
Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis	65
Hepatocyte TIPE2 is a fasting-induced Raf-1 inactivator that drives hepatic gluconeogenesis to maintain glucose homeostasis	64
Impact of fasting on the AMPK and PGC-1α axis in rodent and human skeletal muscle: A systematic review	64
Metabolic and immune dysfunction at the crossroads between type 1 diabetes and neurodegeneration	63
Exercise alleviates neovascular age-related macular degeneration by inhibiting AIM2 inflammasome in myeloid cells	62
Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and R	60
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity	59
RETRACTED: Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease	58
A biological-systems-based analysis using proteomic and metabolic network inference reveals mechanistic insights into hepatic steatosis	56
Editorial Board	55
Response to letter by Muralidhar and Madhivanan: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences	55
Role of Coronary Artery Calcium in the Association Between Hormone Replacement Therapy Status and Incident Death and Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis	55
Comprehensive assessment of the causal effects and metabolite mediators of glucose-lowering drug targets on cardio-renal-liver-metabolic health	55
Editorial Board	55